NEW YORK / RankWire.AI / – On Wednesday, U.S. equities experienced modest gains, buoyed by a sharp decline in long-term Treasury yields. The S&P 500 increased by 16.22 points, or 0.21%, closing at 7,707.98, ending a streak of three consecutive losses. The Dow Jones Industrial Average rose 119.65 points, or 0.22%, finishing the day at 53,463.05. The Nasdaq Composite saw an increase of 41.38 points, or 0.16%, ending at 26,331.09. The decline in government bond yields contributed to the major indexes’ recovery after several sessions of downward pressure from rising borrowing costs.
Bond prices gained ground after the U.S. Treasury Department announced an expansion of liquidity support buybacks for longer-dated government securities. Effective September 9, the maximum purchase amount will increase from $2 billion to at least $4 billion per operation. This adjustment applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity ranges. The higher purchase limits will remain in effect through November 4. The department explained that robust volumes of high-quality offers prompted the decision to boost liquidity operations in these sectors.
Following the announcement, Treasury yields moved downward, reversing part of the recent climb in long-term borrowing costs. The 10-year Treasury yield dropped to approximately 4.65%, while the 30-year yield decreased to about 5.20%. On Tuesday, the 30-year yield reached 5.337%, its highest point since 2007. Since bond yields move inversely to prices, increased demand for government debt pushed yields lower. This retreat alleviated some of the pressure caused by the recent selloff in long-term government bonds.
Healthcare Sector Supports Market Upswing
Wednesday’s market environment saw healthcare stocks providing additional support, with several pharmaceutical companies posting substantial gains. Moderna shares soared 177%, while Merck advanced 12.6% after both firms announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study evaluated personalized mRNA therapy intismeran autogene combined with Keytruda following surgical removal of high-risk melanoma. The trial met its primary endpoint for recurrence-free survival and a key secondary endpoint related to survival without distant metastasis.
This healthcare rally helped counterbalance mixed trading patterns elsewhere, especially within the technology sector. Consumer stocks also contributed to the overall positive sentiment after several major companies released quarterly earnings. Estée Lauder climbed more than 16% after its earnings report, adding to gains across the consumer sector. Additionally, Target and Lowe’s moved higher following their latest financial disclosures. Smaller-cap stocks generally outperformed large-cap indexes, with the Russell 2000 advancing roughly 0.5% as the broader market recovered.
Indexes Break Three-Day Losing Streak
The rally on Wednesday marked the end of a three-session decline for the S&P 500, Dow, and Nasdaq. The recovery was driven by a decrease in long-term yields, which had exerted downward pressure earlier in the week. Despite the gains, the major indexes remain lower for the week at the close. The S&P 500 is approximately 1% below last Friday’s level, while the Dow has fallen around 0.5%, and the Nasdaq remains roughly 1.5% lower.
Year-to-date performance remains positive, despite this week’s setbacks and recent bond market pressures. The S&P 500 has gained about 12.6% since January 1, and the Dow has increased approximately 11.2%. The Nasdaq leads with a roughly 13.3% rise, reflecting its stronger overall performance this year. Wednesday’s session therefore provided a modest recovery for Wall Street, supported by declining Treasury yields and gains in healthcare stocks, lifting all three major U.S. stock indexes.